stacking tirzepatide with semaglutide BPC-157 GLP-1: Guide Semaglutide vs Tirzepatide - Pro

After 4 weeks, your prescriber will raise your dose to 0.5 mg injected under the skin once per week

As a result, less water is reabsorbed from the urine filtrate

Each step up can re-trigger symptoms that had settled

In March 2024, the FDA approved anti-obesity medication (AOM) semaglutide for reduction of the risk of serious heart problems like heart attack, stroke, and cardiovascular death in adults who have both heart disease (CVD) and are overweight or obese (1)

However, indirect effects from weight loss, gastrointestinal symptoms, hormonal changes, or fatigue may temporarily influence sexual function in some patients